Hofseth BioCare ASA
ISIN: NO0010598683 | Ticker: HBC | LEI: 5967007LIEEXZXGGEO44
Country: Norway
Our mission is to explore the medical and pharmaceutical potential in compounds from our products, derived from an innovative hydrolysis technology. In the years to come we are confident – and research from some of the world leading university and hospitals clearly indicates – that our technology could become the basis of tomorrow's medicine.
In addition to the potential in becoming the medicine of tomorrow, HBC has an established industry that develops high-value ingredients and finished products for the nutrition market. Our products are present in 40 different countries throughout the world.
The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources.
Hofseth BioCare's headquarters are in Ålesund, Norway with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
2000
Served areaWorldwide
HeadquartersKipervikgata 13, 6003 Ålesund – Norway
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 459,134,000.00 | 415,973,000.00 | 411,030,000.00 |
| Noncurrent Assets | N/A | 187,664,000.00 | 245,662,000.00 | 235,282,000.00 |
| Fixtures And Fittings | N/A | 847,000.00 | 2,281,000.00 | 2,592,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 42,434,000.00 | 53,055,000.00 | 60,588,000.00 |
| Copyrights Patents And Other Industrial Property Rights Service And Operating Rights | N/A | 42,434,000.00 | 53,055,000.00 | N/A |
| Investments In Associates Accounted For Using Equity Method | N/A | 5,733,000.00 | 5,764,000.00 | 5,559,000.00 |
| Investments In Subsidiaries | N/A | 0.00 | 0.00 | 0.00 |
| Other Noncurrent Financial Assets | N/A | 1,542,000.00 | 1,012,000.00 | 340,000.00 |
| Current Assets | N/A | 271,470,000.00 | 170,311,000.00 | 175,748,000.00 |
| Inventories | N/A | 73,302,000.00 | 90,813,000.00 | 116,525,000.00 |
| Current Trade Receivables | N/A | 14,267,000.00 | 10,089,000.00 | 14,072,000.00 |
| Other Current Receivables | N/A | 11,066,000.00 | 19,488,000.00 | 12,724,000.00 |
| Cash and cash equivalents | 94,553,000.00 | 172,835,000.00 | 49,921,000.00 | 32,427,000.00 |
| Equity And Liabilities | N/A | 459,134,000.00 | 415,973,000.00 | 411,030,000.00 |
| Equity | 117,749,000.00 | 263,764,000.00 | 140,378,000.00 | 148,030,000.00 |
| Issued Capital | N/A | 3,578,000.00 | 3,578,000.00 | 3,951,000.00 |
| Share Premium | N/A | 236,709,000.00 | 137,485,000.00 | 144,765,000.00 |
| Additional Paidin Capital | N/A | 8,684,000.00 | 0.00 | 0.00 |
| Noncontrolling Interests | N/A | -684,000.00 | -685,000.00 | -686,000.00 |
| Liabilities | N/A | 195,370,000.00 | 275,595,000.00 | 263,000,000.00 |
| Noncurrent Liabilities | N/A | 89,191,000.00 | 124,662,000.00 | 90,772,000.00 |
| Longterm Borrowings | N/A | 3,768,000.00 | 1,352,000.00 | 812,000.00 |
| Current Liabilities | N/A | 106,179,000.00 | 150,933,000.00 | 172,228,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 84,956,000.00 | 124,165,000.00 | 145,752,000.00 |
| Other Current Liabilities | N/A | 9,571,000.00 | 12,249,000.00 | 13,081,000.00 |
| Line item in (nok) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue From Contracts With Customers | 52,514,000.00 | 76,878,000.00 | 119,128,000.00 |
| Other Income | 16,738,000.00 | 10,738,000.00 | 1,320,000.00 |
| Raw Materials And Consumables Used | 39,532,000.00 | 64,517,000.00 | 91,934,000.00 |
| Employee Benefits Expense | 42,641,000.00 | 44,713,000.00 | 57,043,000.00 |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 26,766,000.00 | 29,350,000.00 | 30,412,000.00 |
| Other Expense By Nature | 52,334,000.00 | 67,600,000.00 | 69,677,000.00 |
| Profit Loss From Operating Activities | -92,021,000.00 | -118,565,000.00 | -128,618,000.00 |
| Finance Income | 3,364,000.00 | 3,647,000.00 | 4,568,000.00 |
| Finance Costs | 12,650,000.00 | 11,577,000.00 | 13,136,000.00 |
| Profit Loss Before Tax | -102,091,000.00 | -126,464,000.00 | -137,390,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | -102,091,000.00 | -126,464,000.00 | -137,390,000.00 |
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -102,091,000.00 | -126,464,000.00 | -137,390,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -39,315,000.00 | -17,511,000.00 | -25,712,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | N/A | 55,245,000.00 | 39,208,000.00 | 70,355,000.00 |
| Adjustments For Undistributed Profits Of Associates | N/A | -784,000.00 | 31,000.00 | 204,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 0.00 | 0.00 | 0.00 |
| Cash Flows From Used In Operating Activities | N/A | -61,632,000.00 | -61,779,000.00 | -45,168,000.00 |
| Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | N/A | 6,517,000.00 | 188,000.00 | 0.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 32,575,000.00 | 22,924,000.00 | 4,020,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 21,882,000.00 | 14,827,000.00 | 13,758,000.00 |
| Proceeds From Other Longterm Assets Classified As Investing Activities | N/A | 918,000.00 | 0.00 | N/A |
| Cash Flows From Used In Investing Activities | N/A | -60,056,000.00 | -37,939,000.00 | -17,778,000.00 |
| Proceeds From Issuing Shares | N/A | 245,645,000.00 | 0.00 | 70,777,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 39,021,000.00 | 1,087,000.00 | 0.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 60,974,000.00 | 3,421,000.00 | 2,420,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 9,666,000.00 | 11,469,000.00 | 12,625,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 199,970,000.00 | -23,197,000.00 | 45,452,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 78,282,000.00 | -122,914,000.00 | -17,494,000.00 |
| Cash and cash equivalents | 94,553,000.00 | 172,835,000.00 | 49,921,000.00 | 32,427,000.00 |
Please note that some sums might not add up.
NO0010598683
LEI5967007LIEEXZXGGEO44
SectorAgricultural Products & Services
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.